Arvind Utchanah Email

Chief Financial Officer . Knight Therapeutics

Current Roles

Employees:
932
Revenue:
$187.3M
About
Knight Therapeutics is a pan-American (ex-US) specialty pharmaceutical company focused on acquiring, in licensing, out-licensing, marketing, and commercializing innovative prescription pharmaceuticals in Canada and Latin America. Knight owns Biotoscana Investments S.A., a pan-Latin American specialty pharmaceutical company. Knight Therapeutics Inc.’s shares trade on TSX under the symbol GUD. Headquartered in Montreal, Knight has nearly 700 employees globally.
Knight Therapeutics Address
3400 De Maisonneuve Blvd. W.
Montreal, QC
CAN
Knight Therapeutics Email

#1 Startup Dataset

Growth rates, revenue data, direct competitors and contact details.